-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In order to practice Health China Action and help cancer prevention and control work, on December 26, the launch ceremony of the 2020 First Annual Conference on Cancer Prevention and Control in China supported by Baiji Shenzhou and the "People's Good Doctor Jinshan Tea Flower Program" was held in Beijing under the guidance of the Publicity Group of the Office of the Health China Action Promotion Committee, organized by People's Network People's Health, Co-sponsored by the China Health Promotion Foundation, and supported by Baiji Shenzhou.
Conference of the Chinese People's Congress to take stock of the medical community in 2020 in the field of cancer prevention and treatment of major progress, and recognized a number of outstanding contributions of young and middle-aged experts.
"People's Good Doctor Jinshan Tea Flower Program" launch ceremony site Chinese Academy of Engineering, Professor of Oncology Hospital of the Chinese Academy of Medical Sciences, Honorary Director of GCP Center Professor Sun Yan, Chief Expert of Shanghai Chest Hospital Clinical Center, Special Grant Recipient of the State Council Professor Liao Meilin, Director of the Cancer Prevention and Control Center of Zhongshan University, Mentor, Professor Guan Zhongzhen, director of the National Anti-Tumor Drug Clinical Trial Research Center and executive director of the China Anti-Cancer Association, three respected seniors in the field of anti-oncology, sent a message to young and middle-aged doctors at the conference, encouraging the vast number of young and middle-aged doctors to forge ahead and continue to contribute to improving the survival level of cancer patients in China.
Lu Chunshan, a second-level inspector in the Planning Development and Information Technology Division of the National Health and Health Commission and head of the publicity group of the Office of the Health China Action Promotion Committee, said in a speech at the conference that cancer prevention and treatment is an important public health issue concerning people's sense of well-being, well-being and security, and one of the 15 major special actions of the Health China Initiative.
to strengthen popular science publicity and education, improve public awareness of various high-risk factors of cancer, enhance awareness of early screening and other tasks are still difficult.
Lu Chunshan called on the market, society and other diverse subjects and the government to form a joint effort to build a shared healthy China with people's health as the center.
" 'People's Good Doctor Jinshan Tea Flower Program' is a positive attempt to use the People's Network People's Health and other carriers, the 'China Cancer Prevention and Control Annual Congress' this platform, to become a service and promote the national cancer prevention and control action of high-quality brands.
," Lu Chunshan said.
Speaking at the conference, Dr. Wu Xiaobin, General Manager and President of Baiji Shenzhou China, said that in the field of cancer, the successive approval of domestic PD-1 monoantigens on the market has not only greatly improved the accessability of domestic anti-cancer drugs, but also greatly reduced the treatment burden of domestic patients.
" on the international stage, the rapid development of domestic innovative drugs will also benefit patients in developed countries and Belt and Road countries, and even change the pattern of drug use in the world.
," Dr. Wu xiaobin said.
Life-long Director of Guangdong Provincial People's Hospital, Honorary Director of Guangdong Lung Cancer Research Institute, Chairman of the China Chest Cancer Collaboration Group Professor Wu Yilong, Vice President of Peking University Cancer Hospital, Director of Digestive Oncology Professor Shen Lin, Academician of the Chinese Academy of Sciences, Director of Zhongshan Hospital affiliated with Fudan University, Director of the Shanghai Institute of Hepatology, Vice President of Fudan University Affiliated Oncology Hospital, Professor Ye Dingwei, Director of the Institute of Urological Oncology, Peking University Cancer Hospital Professor Zhu Jun, Secretary of the Party Committee and Director of The University of Internal Medicine, Professor Ma Jun, Executive Vice President of Sun Yat-sen University Cancer Prevention and Control Center, and many other experts from the field of cancer prevention and treatment have made significant progress in the field of cancer prevention and treatment, esophageal gastric cancer treatment, liver cancer diagnosis and treatment, urological tumor diagnosis and treatment, lymphoma diagnosis and treatment, nasopharyngeal cancer diagnosis and treatment, etc.
At the same time, the conference also held the "People's Good Doctor Jinshan Tea Flower Program" launch ceremony, and in lung cancer, esophageal gastric cancer, liver cancer, urinary tumors, lymphoma, nasopharyngeal cancer in six areas selected a total of 35 outstanding contribution awards and 72 outstanding model award winners.
It is learned that the "Golden Mountain Tea Flower Program" follow-up will be based on the annual, each year focused on the promotion of a group of young experts in the field of cancer prevention and control to make outstanding contributions, while the event will also form an annual panel of experts, responsible for the selection of young experts for guidance and promotion.
People's Health relies on the "People's Good Doctor" platform to customize services for chief experts, special experts and young experts, including but not limited to famous medical brand building services, academic display and exchange services, popular science communication services, research results transformation services.
。